$AUUD
Auddia Inc

2023 Q4 Form 10-Q Financial Statement

#000168316823008138 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $50.87K $43.47K $32.71K
YoY Change -1.95% 32.9% -10.38%
Gross Profit -$50.87K -$43.47K -$32.71K
YoY Change -1.95% 32.9% -10.38%
Gross Profit Margin
Selling, General & Admin $1.311M $1.094M $839.1K
YoY Change 19.09% 30.35% -55.75%
% of Gross Profit
Research & Development $163.4K $227.1K $181.6K
YoY Change -5.7% 25.08% 52.19%
% of Gross Profit
Depreciation & Amortization $490.0K $6.193K $274.8K
YoY Change 81.72% -97.75% 249.0%
% of Gross Profit
Operating Expenses $1.964M $1.830M $1.328M
YoY Change 27.25% 37.74% -34.1%
Operating Profit -$2.015M -$1.830M -$1.328M
YoY Change 26.3% 37.74% -35.27%
Interest Expense -$197.7K -$286.9K -$2.020K
YoY Change 17.72% 14103.96% -173.99%
% of Operating Profit
Other Income/Expense, Net -$286.9K -$2.023K
YoY Change 14082.9% -174.24%
Pretax Income -$2.213M -$2.116M -$1.330M
YoY Change 25.48% 59.1% -35.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.213M -$2.116M -$1.330M
YoY Change 25.48% 59.1% -35.09%
Net Earnings / Revenue
Basic Earnings Per Share -$0.11 -$0.11
Diluted Earnings Per Share -$2.77 -$0.11 -$0.11
COMMON SHARES
Basic Shares Outstanding 19.95M shares 19.95M shares 12.51M shares
Diluted Shares Outstanding 19.95M shares 12.51M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $804.6K $2.200M $957.1K
YoY Change -51.57% 129.82% -88.16%
Cash & Equivalents $804.6K $2.200M $1.000M
Short-Term Investments
Other Short-Term Assets $7.150K $56.70K $53.98K
YoY Change 5.04%
Inventory
Prepaid Expenses $50.61K
Receivables $494.00 $574.00 $35.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $834.0K $2.257M $1.011M
YoY Change -49.8% 123.21% -87.49%
LONG-TERM ASSETS
Property, Plant & Equipment $18.10K $22.08K $48.05K
YoY Change -55.94% -54.03% -25.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $203.0K $217.6K $0.00
YoY Change -26.1% -100.0%
Total Long-Term Assets $3.569M $3.785M $4.191M
YoY Change -19.8% -9.68% 46.4%
TOTAL ASSETS
Total Short-Term Assets $834.0K $2.257M $1.011M
Total Long-Term Assets $3.569M $3.785M $4.191M
Total Assets $4.403M $6.042M $5.202M
YoY Change -27.96% 16.15% -52.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $424.5K $269.2K $303.4K
YoY Change 46.41% -11.29% -13.22%
Accrued Expenses $470.2K $304.0K
YoY Change 1572.64%
Deferred Revenue
YoY Change
Short-Term Debt $3.025M $2.994M $0.00
YoY Change 70.33% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.983M $3.627M $435.0K
YoY Change 76.11% 733.88% -30.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.983M $3.627M $435.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.983M $3.627M $435.0K
YoY Change 76.11% 733.87% -30.42%
SHAREHOLDERS EQUITY
Retained Earnings -$80.54M -$78.33M -$69.97M
YoY Change 12.28% 11.94%
Common Stock $854.00 $19.95K $12.51K
YoY Change -93.25% 59.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $420.4K $2.415M $4.767M
YoY Change
Total Liabilities & Shareholders Equity $4.403M $6.042M $5.202M
YoY Change -27.96% 16.15% -52.47%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$2.213M -$2.116M -$1.330M
YoY Change 25.48% 59.1% -35.09%
Depreciation, Depletion And Amortization $490.0K $6.193K $274.8K
YoY Change 81.72% -97.75% 249.0%
Cash From Operating Activities -$1.099M -$1.190M -$989.3K
YoY Change -2.78% 20.31% -16.62%
INVESTING ACTIVITIES
Capital Expenditures $288.4K $213.7K -$394.9K
YoY Change 13.63% -154.12% 0.72%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$288.4K -$213.7K -$394.9K
YoY Change 13.63% -45.88% 0.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.500K -1.530K 0.000
YoY Change -100.36% -100.0%
NET CHANGE
Cash From Operating Activities -1.099M -1.190M -989.3K
Cash From Investing Activities -288.4K -213.7K -394.9K
Cash From Financing Activities -7.500K -1.530K 0.000
Net Change In Cash -1.395M -1.405M -1.384M
YoY Change -298.08% 1.54% -192.35%
FREE CASH FLOW
Cash From Operating Activities -$1.099M -$1.190M -$989.3K
Capital Expenditures $288.4K $213.7K -$394.9K
Free Cash Flow -$1.388M -$1.404M -$594.4K
YoY Change 0.23% 136.21% -25.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001554818
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40071
dei Entity Registrant Name
EntityRegistrantName
AUDDIA INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4257218
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Central Ave.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Boulder
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80301
dei City Area Code
CityAreaCode
(303)
dei Local Phone Number
LocalPhoneNumber
219-9771
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19947223 shares
CY2023Q3 us-gaap Cash
Cash
2199678 usd
CY2022Q4 us-gaap Cash
Cash
1661434 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
574 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
56704 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
2256956 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1661571 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22084 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41080 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3545610 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4134225 usd
CY2023Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
170259 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
222896 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
47364 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
51754 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3785317 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
4449955 usd
CY2023Q3 us-gaap Assets
Assets
6042273 usd
CY2022Q4 us-gaap Assets
Assets
6111526 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
587641 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
324138 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
2993639 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1775956 usd
CY2023Q3 AUUD Stock Awards Liability
StockAwardsLiability
45981 usd
CY2022Q4 AUUD Stock Awards Liability
StockAwardsLiability
161349 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3627261 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2261443 usd
CY2023Q3 us-gaap Liabilities
Liabilities
3627261 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2261443 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19947223 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19947223 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3850083 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6042273 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6111526 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12654949 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12654949 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
19947 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12654 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
80725555 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75573263 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78330490 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71735834 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2415012 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
43470 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
32712 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
130809 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
128806 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
316297 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
298924 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
765176 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1396010 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227133 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
181596 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
617622 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
481611 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
777496 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
540220 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2596831 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2400503 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
465166 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
274839 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1350820 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
721971 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1829562 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1328291 usd
us-gaap Operating Expenses
OperatingExpenses
5461258 usd
us-gaap Operating Expenses
OperatingExpenses
5128901 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1829562 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1328291 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5461258 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5128901 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-286920 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2023 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1133398 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5058 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-286920 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2023 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1133398 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5058 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2116482 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1330314 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6594656 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5133959 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2116482 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1330314 usd
us-gaap Net Income Loss
NetIncomeLoss
-6594656 usd
us-gaap Net Income Loss
NetIncomeLoss
-5133959 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19947223 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19947223 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12514763 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12514763 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16043086 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16043086 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12498206 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12498206 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3850083 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
42797 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
357680 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2155312 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2095247 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3963884 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-42797 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
383004 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224856 usd
CY2023Q2 AUUD Revaluation Of Sharebased Compensation Liability
RevaluationOfSharebasedCompensationLiability
30445 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2322862 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4331777 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
217141 usd
CY2023Q3 AUUD Revaluation Of Sharebased Compensation Liability
RevaluationOfSharebasedCompensationLiability
-17424 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2116482 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2415012 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
9410937 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
385908 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-128534 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1753258 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7915053 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
285921 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7262 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2050385 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6143327 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26657 usd
CY2022Q3 AUUD Revaluation Of Sharebased Compensation Liability
RevaluationOfSharebasedCompensationLiability
-72315 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1330314 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
4767353 usd
us-gaap Profit Loss
ProfitLoss
-6594656 usd
us-gaap Profit Loss
ProfitLoss
-5133959 usd
AUUD Finance Charge Associated With Debt To Equity Conversion
FinanceChargeAssociatedWithDebtToEquityConversion
850688 usd
AUUD Finance Charge Associated With Debt To Equity Conversion
FinanceChargeAssociatedWithDebtToEquityConversion
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1350820 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
721971 usd
us-gaap Share Based Compensation
ShareBasedCompensation
799677 usd
us-gaap Share Based Compensation
ShareBasedCompensation
698486 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
437 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-52 usd
us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
56705 usd
us-gaap Increase Decrease In Prepaid Insurance
IncreaseDecreaseInPrepaidInsurance
-0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4390 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1065 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
241269 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
92403 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3404954 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3622112 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
743208 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1673517 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3809 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-743208 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1677326 usd
AUUD Net Settlement Of Sharebased Compensation Liability
NetSettlementOfSharebasedCompensationLiability
80115 usd
AUUD Net Settlement Of Sharebased Compensation Liability
NetSettlementOfSharebasedCompensationLiability
88723 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
750000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4016521 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4686406 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88723 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
538244 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5388161 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1661434 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6345291 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2199678 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
957130 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
us-gaap Interest Paid Net
InterestPaidNet
5058 usd
AUUD Reclassification Of Deferred Offering Cost
ReclassificationOfDeferredOfferingCost
52637 usd
AUUD Reclassification Of Deferred Offering Cost
ReclassificationOfDeferredOfferingCost
0 usd
AUUD Original Issue Discount And Issuance Of Warrants On Related Party Debt
OriginalIssueDiscountAndIssuanceOfWarrantsOnRelatedPartyDebt
458004 usd
AUUD Original Issue Discount And Issuance Of Warrants On Related Party Debt
OriginalIssueDiscountAndIssuanceOfWarrantsOnRelatedPartyDebt
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zQgchGz7sv2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline"><span id="xdx_86F_zAZzApnKaFB9">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed financial statements include some amounts that are based on management's best estimates and judgments. The most significant estimates relate to valuation of capital stock, warrants and options to purchase shares of the Company's common stock, and the estimated recoverability and amortization period for capitalized software development costs. These estimates may be adjusted as more current information becomes available, and any adjustment could be significant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q3 us-gaap Cash
Cash
2199678 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1900000 usd
CY2022Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1400000 usd
CY2023Q3 us-gaap Payments For Software
PaymentsForSoftware
213705 usd
CY2022Q3 us-gaap Payments For Software
PaymentsForSoftware
394893 usd
us-gaap Payments For Software
PaymentsForSoftware
743208 usd
us-gaap Payments For Software
PaymentsForSoftware
1673517 usd
CY2023Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
458973 usd
CY2022Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
262703 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1331823 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
693441 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85118 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
66121 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22084 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41080 usd
CY2023Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
3823647 usd
CY2022Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2491824 usd
CY2023Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3545610 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4134225 usd
CY2023Q3 us-gaap Depreciation
Depreciation
6193 usd
CY2022Q3 us-gaap Depreciation
Depreciation
12136 usd
CY2023Q3 AUUD Amortization Of Software Development Costs
AmortizationOfSoftwareDevelopmentCosts
458973 usd
CY2022Q3 AUUD Amortization Of Software Development Costs
AmortizationOfSoftwareDevelopmentCosts
262703 usd
us-gaap Depreciation
Depreciation
18997 usd
us-gaap Depreciation
Depreciation
28529 usd
AUUD Amortization Of Software Development Costs
AmortizationOfSoftwareDevelopmentCosts
1331823 usd
AUUD Amortization Of Software Development Costs
AmortizationOfSoftwareDevelopmentCosts
693441 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
269159 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
289955 usd
CY2023Q3 AUUD Credit Cards Payable
CreditCardsPayable
14517 usd
CY2022Q4 AUUD Credit Cards Payable
CreditCardsPayable
6072 usd
CY2023Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
303965 usd
CY2022Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
28111 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
587641 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
324138 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
12053 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
39935 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
49491 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
83117 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2095247 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4331777 usd
us-gaap Share Based Compensation
ShareBasedCompensation
799677 usd
us-gaap Share Based Compensation
ShareBasedCompensation
698486 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1447278 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7079016 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6271219 shares

Files In Submission

Name View Source Status
0001683168-23-008138-index-headers.html Edgar Link pending
0001683168-23-008138-index.html Edgar Link pending
0001683168-23-008138.txt Edgar Link pending
0001683168-23-008138-xbrl.zip Edgar Link pending
auddia_ex3101.htm Edgar Link pending
auddia_ex3201.htm Edgar Link pending
auddia_i10q-093023.htm Edgar Link pending
auud-20230930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
auud-20230930_lab.xml Edgar Link unprocessable
auud-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
auddia_i10q-093023_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
auud-20230930_cal.xml Edgar Link unprocessable
auud-20230930_def.xml Edgar Link unprocessable